SGLT2 Inhibitors and Cardiovascular Outcomes in Patients With Moderate-to-Severe Psoriasis Receiving Biologic Therapy: A Propensity Score-Matched Cohort Study

Actas Dermo-Sifiliográficas · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles